Analysts’ price target changes for Wednesday, January 8th:
AbCellera Biologics (NASDAQ:ABCL) had its price target lowered by KeyCorp from $5.00 to $4.00. They currently have an overweight rating on the stock.
Absci (NASDAQ:ABSI) had its price target lowered by KeyCorp from $6.00 to $5.00. The firm currently has an overweight rating on the stock.
American Eagle Outfitters (NYSE:AEO) had its target price trimmed by JPMorgan Chase & Co. from $23.00 to $20.00. They currently have a neutral rating on the stock.
AppLovin (NASDAQ:APP) had its price target boosted by Jefferies Financial Group Inc. from $400.00 to $425.00. They currently have a buy rating on the stock.
Boot Barn (NYSE:BOOT) had its target price raised by JPMorgan Chase & Co. from $181.00 to $188.00. They currently have an overweight rating on the stock.
Doximity (NASDAQ:DOCS) had its price target cut by KeyCorp from $70.00 to $65.00. KeyCorp currently has an overweight rating on the stock.
Dycom Industries (NYSE:DY) had its price target increased by KeyCorp from $227.00 to $229.00. KeyCorp currently has an overweight rating on the stock.
Five Below (NASDAQ:FIVE) had its target price reduced by JPMorgan Chase & Co. from $110.00 to $107.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.
Fluor (NYSE:FLR) had its price target raised by KeyCorp from $59.00 to $60.00. KeyCorp currently has an overweight rating on the stock.
GoodRx (NASDAQ:GDRX) had its price target reduced by KeyCorp from $7.00 to $6.00. They currently have an overweight rating on the stock.
KBR (NYSE:KBR) had its price target cut by KeyCorp from $78.00 to $70.00. They currently have an overweight rating on the stock.
LifeMD (NASDAQ:LFMD) had its price target reduced by KeyCorp from $10.00 to $7.00. KeyCorp currently has an overweight rating on the stock.
Lululemon Athletica (NASDAQ:LULU) had its target price boosted by JPMorgan Chase & Co. from $425.00 to $428.00. The firm currently has an overweight rating on the stock.
Macy’s (NYSE:M) had its price target cut by JPMorgan Chase & Co. from $21.00 to $20.00. The firm currently has an overweight rating on the stock.
Malibu Boats (NASDAQ:MBUU) had its target price cut by KeyCorp from $50.00 to $45.00. They currently have an overweight rating on the stock.
MasTec (NYSE:MTZ) had its target price boosted by KeyCorp from $153.00 to $168.00. KeyCorp currently has an overweight rating on the stock.
Oddity Tech (NASDAQ:ODD) had its target price boosted by KeyCorp from $50.00 to $52.00. The firm currently has an overweight rating on the stock.
OneWater Marine (NASDAQ:ONEW) had its price target reduced by KeyCorp from $27.00 to $22.00. KeyCorp currently has an overweight rating on the stock.
Phreesia (NYSE:PHR) had its target price increased by KeyCorp from $28.00 to $30.00. They currently have an overweight rating on the stock.
Parsons (NYSE:PSN) had its price target cut by KeyCorp from $122.00 to $102.00. The firm currently has an overweight rating on the stock.
RPM International (NYSE:RPM) had its price target lowered by JPMorgan Chase & Co. from $126.00 to $124.00. The firm currently has a neutral rating on the stock.
Recursion Pharmaceuticals (NASDAQ:RXRX) had its price target cut by KeyCorp from $12.00 to $10.00. The firm currently has an overweight rating on the stock.
Simulations Plus (NASDAQ:SLP) had its price target lowered by KeyCorp from $40.00 to $35.00. KeyCorp currently has an overweight rating on the stock.
SpringWorks Therapeutics (NASDAQ:SWTX) had its target price trimmed by Guggenheim from $80.00 to $78.00. They currently have a buy rating on the stock.
Urban Outfitters (NASDAQ:URBN) had its price target raised by JPMorgan Chase & Co. from $46.00 to $54.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Veeva Systems (NYSE:VEEV) had its price target cut by KeyCorp from $285.00 to $255.00. KeyCorp currently has an overweight rating on the stock.
YETI (NYSE:YETI) had its price target lowered by KeyCorp from $36.00 to $35.00. KeyCorp currently has an underweight rating on the stock.
Receive News & Ratings for AbCellera Biologics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbCellera Biologics Inc and related companies with MarketBeat.com's FREE daily email newsletter.
